Australia Stocks Close Higher; Healthcare, Staples, Financials Lead

Australia stocks finished higher on Monday as gains in the healthcare, consumer staples and financials sectors offset weakness in materials. The S&P/ASX 200 rose 0.10% at the close in Sydney, recovering slightly from Friday’s more-than-two-month low. Declining stocks still outnumbered advancers, while oil prices climbed more than 2% on Middle East supply concerns and the ASX 200 VIX fell.

ASX 200 Edges Up 0.10% as Healthcare and Staples Lead; Telix Surges on FDA Approval

At the close in Sydney, the S&P/ASX 200 advanced 0.10%. Healthcare stocks jumped around 1%, helped by a more than 1.5% rise in heavyweight CSL and a strong performance from Telix Pharmaceuticals. Consumer staples climbed approximately 0.4%, with Woolworths and Coles both adding more than 1%. Financials also contributed positively.

The session’s best performers on the S&P/ASX 200 were Lovisa Holdings Ltd (ASX:LOV), which rose 5.73% or 1.24 points to close at 22.87; Nine Entertainment Co Holdings Ltd (ASX:NEC), up 5.19% or 0.04 points to 0.81; and Telix Pharmaceuticals Ltd (ASX:TLX), which gained 4.72% or 0.74 points to 16.41. Telix’s advance followed U.S. FDA approval of its brain-cancer imaging drug Pixclara (floretyrosine F 18), the first FDA-approved FET-PET agent for differentiating recurrent or progressive glioma from treatment-related changes in adults and pediatric patients.

The worst performers were Megaport Ltd (ASX:MP1), which fell 7.80% or 1.39 points to 16.44; Paladin Energy Ltd (ASX:PDN), down 6.91% or 0.71 points to 9.57; and Chorus Ltd (ASX:CNU), which declined 5.17% or 0.37 points to 6.78 and hit a 52-week low. Falling stocks outnumbered advancing ones on the Sydney Stock Exchange by 604 to 460, with 403 ending unchanged.

The S&P/ASX 200 VIX, measuring implied volatility of S&P/ASX 200 options, fell 2.12% to 14.05. In commodities, December gold futures dropped 0.87% or $38.39 to $4,370.51 a troy ounce. October crude oil rose 2.28% or $2.28 to $102.33 a barrel, while the November Brent contract climbed 2.22% or $2.32 to $106.93 a barrel. AUD/USD was little changed near 0.71 and AUD/JPY held around 110.16. The U.S. Dollar Index futures rose 0.31% to 99.14.

Markets Rebound Selectively After Steep Weekly Drop as Telix Catalyst and Defensive Rotation Offset Mining Weakness

The modest advance came after the S&P/ASX 200 posted its steepest weekly decline since mid-March (down roughly 2.1–3% for the week ending Friday), when the index closed at 8,741.20—its lowest level since early July. Investors took selective profit or rotated into defensive and growth-oriented names after the prior week’s risk-off move driven by higher oil prices, rising bond yields and renewed rate-hike expectations.

Telix’s FDA approval provided a clear company-specific catalyst for healthcare. Broader sector strength in staples and financials reflected a preference for relatively defensive exposures while materials remained under pressure from softer iron ore and copper prices and ongoing uranium-stock weakness. Higher oil prices, triggered by weekend Houthi strikes on Saudi facilities and Iranian actions in the Gulf that compounded earlier pipeline disruptions, supported energy stocks but weighed on risk appetite overall and kept mining shares in check.

ASX 200 Rebounds Cautiously from Two-Month Low After Miner-Led Selloff and Rising Yields

Friday’s close of 8,741.20 marked a more-than-two-month low after heavyweight miners, led by BHP (down more than 4% that day), slumped on weaker commodity prices. The materials sector had already suffered sharp losses earlier in the week. Global sentiment was clouded by Middle East tensions that pushed oil above $100 a barrel and lifted inflation concerns, prompting investors to reduce exposure to cyclical and resource-heavy stocks. Australian government bond yields had also climbed above 5%, their highest levels in years.

The index opened Monday near the prior close and traded in a relatively narrow range (roughly 8,734–8,768 according to multiple data sources) before finishing modestly higher. Breadth remained weak, consistent with a cautious recovery rather than a broad-based rally. Gold’s decline contrasted with oil’s strength, highlighting divergent commodity dynamics.

Focus Shifts to Fed Decision and Oil Volatility as Markets Watch Healthcare Leadership and Materials Stabilisation

Attention turns to this week’s central-bank meetings, particularly the U.S. Federal Reserve decision, where markets have priced a high probability of a rate increase following recent inflation data. Continued Middle East developments will keep oil prices volatile and influence inflation expectations and risk appetite. Local focus will remain on whether healthcare and staples can sustain leadership, whether materials stabilise, and how the ASX 200 responds to any further moves in the Australian dollar and global yields. Traders will also monitor company-specific news flow, including any follow-through on Telix’s regulatory milestone and updates from resources and technology names that dominated both ends of Monday’s leaderboard.

Australia stocks higher as reported by market data summaries consistent with Reuters and other real-time sources covering the September 14, 2026 session.